Multiple Social Disadvantages Linked to Progressively Worse JIA and Pediatric LupusMarch 26, 2024Rheumatology
PT Delivered Via Telemedicine Proves Noninferior to In-Person Care for Chronic Knee PainMarch 20, 2024OsteoarthritisMusculoskeletal DisordersPainRheumatology
RA Outcomes Worsened by Depression and Anxiety, Signaling Need for Multidisciplinary ActionMarch 13, 2024RheumatologyMental Health
Second FDA-Approved Tocilizumab Biosimilar Has Intravenous, Subcutaneous FormulationsMarch 8, 2024PediatricsRare DiseasesMusculoskeletal DisordersRheumatology
No Increase in Autoimmune Risk Seen With GLP-1 Receptor Agonists and SGLT2 InhibitorsMarch 7, 2024DiabetesMixed TopicsRheumatology
First Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024OncologyRheumatologyEndocrinology
Osteoporosis Drug Denosumab May Confer Lower Risk for DiabetesMarch 4, 2024DiabetesEndocrinologyRheumatology
Study Evaluates Factors Driving Fatigue in Patients With Psoriasis, PsAMarch 4, 2024DermatologyRheumatology
Unexpectedly Helpful Effects of Drugs Used For Other ReasonsMarch 1, 2024RheumatologyOncologyCardiologyMusculoskeletal Disorders
Gout Increases the Risk for a Wide Range of Cardiovascular DiseasesFebruary 27, 2024CardiologyRheumatology
FDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024PediatricsGastroenterologyRare DiseasesMusculoskeletal DisordersRheumatologyDermatology
Mixing Paxlovid With Specific Immunosuppressants Risks Serious Adverse ReactionsFebruary 14, 2024COVID-19 UpdatesInfectious DiseasesRheumatologyNephrologyMixed Topics
Are There Benefits to Taking GLP-1 Receptor Agonists Before Joint Surgery?February 14, 2024OsteoarthritisRheumatologyMusculoskeletal Disorders
